Difference between revisions of "Category:BTK inhibitors"
Jump to navigation
Jump to search
m |
m |
||
| Line 4: | Line 4: | ||
<references/> | <references/> | ||
| − | [[Category: | + | [[Category:Tyrosine kinase inhibitors]] |
Latest revision as of 21:55, 22 January 2021
A class of drugs that inhibit Bruton's tyrosine kinase (BTK). The first specific drug approved in this class is Ibrutinib (Imbruvica), although Dasatinib (Sprycel) has some demonstrated degree of BTK inhibition[1].
References
Pages in category "BTK inhibitors"
The following 8 pages are in this category, out of 8 total.